Andreas Tzakis , Weston, USA – Advances in vascular reconstruction techniques in recent years has transformed the concept of multi-visceral or cluster transplantations from the very forefront of… read more.
Reducing or eliminating the need for chronic immunosuppressive therapy by inducing tolerance in the recipient immune system would have an astounding impact on clinical practice and scientists all… read more.
by Maria Dalby – Kidney transplants could in principle last forever – the common assumption that kidney transplants inevitably deteriorate and fail is not supported by the latest… read more.
by Maria Dalby – Donor-specific anti-human leukocyte antigen (HLA) antibodies, or DSAs, have emerged in recent years as one of the most important factors for predicting the outcome… read more.
Johns Hopkins researchers see 21-fold increase in a single day. A social media push boosted the number of people who registered themselves as organ donors 21-fold in a… read more.
Taken from the NEJM – by Bruce Sylvester – Three biomarkers in the urine of kidney transplant recipients can be used to diagnose and predict transplant rejection, researchers… read more.
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.
Erasmus virus resets cells’ genes and causes breathing distress and kidney failure. A new virus that causes severe breathing distress and kidney failure elicits a distinctive airway cell… read more.
by Maria Dalby reporting on the presentation by Steve Woodle, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. The future of treatment of antibody-mediated rejection (AMR) may… read more.
by Maria Dalby reporting on the presentation by William McKane, Sheffield Teaching Hospitals NHS Foundation Trust & Declan de Freitas, Beaumont Hospital, Dublin, Ireland. Pre-transplant and de novo… read more.
by Maria Dalby reporting on the presentation by Adam McLean, Hammersmith Hospital, London. Tacrolimus administered once daily in an extended-release formulation is as safe and effective as conventional… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
